Orthotropic live transplantation for cirrhosis from hepatitis C virus leads to correction of factor IX deficiency allowing for ankle arthroplasty without factor replacement in a patient with moderate haemophilia B

Blood Coagul Fibrinolysis. 2018 Jan;29(1):131-134. doi: 10.1097/MBC.0000000000000692.

Abstract

: Liver transplantation is one of the treatments for haemophilic patients having severe liver cirrhosis who are infected with the hepatitis C virus. Patients with haemophilia can develop arthroplasty requiring surgical intervention, and the surgical outcomes of patients undergoing such procedures after liver transplant has not been reported. Treatment for arthropathy is important for improving the quality of life for patients who survive after liver transplantation. We report the first case of ankle arthroscopic arthrodesis in a patient with haemophilia B after undergoing living donor liver transplantation. We carefully monitored the patient's factor IX (FIX) plasma levels during his perioperative period, and we successfully performed his arthroscopic ankle arthrodesis without administration of any additional FIX concentrates. Our case has demonstrated the feasibility of joint surgery after liver transplantation without administration of additional clotting factors while monitoring FIX activity.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Ankle / pathology*
  • Arthroplasty / methods*
  • Hemophilia B
  • Hepatitis C / surgery*
  • Humans
  • Liver Cirrhosis / surgery*
  • Liver Transplantation / methods*
  • Male